Healthpeak Properties, Inc. (DOC) stock
Close on Oct 30, 2026Market cap $13.12BP/E 54.4Yield 6.41%
Earnings
Healthpeak Properties's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Healthpeak Properties's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Oct 22, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026during market hours | $771.58M | +11.1% | $0.08 | $0.46 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026during market hours | $752.95M | +7.1% | $0.28 | $0.45 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 2, 2026during market hours | $719.40M | +3.1% | – | $0.47 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 23, 2025during market hours | $705.87M | +0.8% | -$0.17 | $0.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 24, 2025during market hours | $694.35M | -0.2% | $0.05 | $0.46 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 24, 2025during market hours | $702.89M | +15.9% | $0.06 | $0.46 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 3, 2025during market hours | $697.99M | +26.1% | $0.01 | $0.46 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 24, 2024during market hours | $700.40M | +25.9% | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024during market hours | $695.50M | +27.5% | $0.21 | $0.45 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024during market hours | $606.56M | +15.4% | $0.01 | $0.45 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 8, 2024during market hours | $553.65M | +5.6% | $0.13 | $0.46 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 30, 2023before the open | $556.24M | +6.9% | $0.12 | $0.45 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023during market hours | $545.43M | +5.3% | $0.09 | $0.45 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023during market hours | $525.68M | +5.5% | $0.22 | $0.42 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 7, 2023during market hours | $524.47M | +8.5% | $0.01 | $0.44 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 1, 2022during market hours | $520.41M | +8.1% | $0.65 | $0.43 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 2, 2022during market hours | $517.93M | – | $0.13 | $0.44 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 3, 2022during market hours | $498.37M | – | $0.13 | $0.43 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 8, 2022during market hours | $483.21M | – | $0.05 | $0.41 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 2, 2021during market hours | $481.47M | – | $0.10 | $0.40 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021during market hours | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 9, 2021during market hours | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Nov 2, 2020during market hours | – | – | – | – | Release |
| Q2 FY2020ended Jun 30, 2020 | Aug 4, 2020during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Healthpeak Properties's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total Merger-Combined Same-Store Cash (Adjusted) NOI growthnon-GAAP | FY2026 | -1% – +1% | – | New | Feb 2, 2026 |
| Diluted earnings per common shareGAAP | FY2026 | $0.48 – $0.52 | $0.46 – $0.50 | Raised | Aug 4, 2026 |
| Diluted FFO as Adjusted per sharenon-GAAP | FY2026 | $1.73 – $1.77 | $1.68 – $1.72 | Raised | Aug 4, 2026 |
| Total Same-Store Cash (Adjusted) NOInon-GAAP | FY2026 | 0% – +1.5% | – | Raised | Aug 4, 2026 |
| Total Same-Store Cash (Adjusted) NOI growthnon-GAAP | FY2026 | -1% – +1% | – | New | May 5, 2026 |
Guidance vs results
The last range Healthpeak Properties gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Diluted FFO as Adjusted per share | $1.81 – $1.87 | $1.85Σ4Q | Within range |
Guidance history
Every forecast Healthpeak Properties put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 4, 2026 | Diluted FFO as Adjusted per share | FY2026 | $1.73 – $1.77 | Raised |
| Aug 4, 2026 | Diluted earnings per common share | FY2026 | $0.48 – $0.52 | Raised |
| Aug 4, 2026 | Total Same-Store Cash (Adjusted) NOI | FY2026 | 0% – +1.5% | Raised |
| May 5, 2026 | Diluted Nareit FFO per share | FY2026 | $1.68 – $1.72 | Lowered |
| May 5, 2026 | Diluted FFO as Adjusted per share | FY2026 | $1.71 – $1.75 | Raised |
| May 5, 2026 | Diluted earnings per common share | FY2026 | $0.46 – $0.50 | Raised |
| May 5, 2026 | Total Same-Store Cash (Adjusted) NOI growth | FY2026 | -1% – +1% | New |
| Feb 2, 2026 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2026 | -1% – +1% | New |
| Feb 2, 2026 | Diluted Nareit FFO per share | FY2026 | $1.70 – $1.74 | New |
| Feb 2, 2026 | Diluted FFO as Adjusted per share | FY2026 | $1.70 – $1.74 | Reaffirmed |
| Feb 2, 2026 | Diluted earnings per common share | FY2026 | $0.34 – $0.38 | New |
| Oct 23, 2025 | Diluted FFO as Adjusted per share | FY2025 | $1.81 – $1.87 | New |
| Oct 23, 2025 | Diluted earnings per common share | FY2025 | $0.00 – $0.06 | Lowered |
| Oct 23, 2025 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2025 | +3% – +4% | Reaffirmed |
| Oct 23, 2025 | Diluted Nareit FFO per share | FY2025 | $1.78 – $1.84 | Reaffirmed |
| Jul 24, 2025 | Diluted earnings per common share | FY2025 | $0.25 – $0.31 | New |
| Jul 24, 2025 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2025 | +3% – +4% | New |
| Jul 24, 2025 | Diluted FFO as Adjusted per share | FY2025 | $1.81 – $1.87 | New |
| Jul 24, 2025 | Diluted Nareit FFO per share | FY2025 | $1.78 – $1.84 | Lowered |
| Apr 24, 2025 | Diluted FFO as Adjusted per share | FY2025 | $1.81 – $1.87 | Reaffirmed |
| Apr 24, 2025 | Diluted earnings per common share | FY2025 | $0.30 – $0.36 | Reaffirmed |
| Apr 24, 2025 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2025 | +3% – +4% | Reaffirmed |
| Apr 24, 2025 | Diluted Nareit FFO per share | FY2025 | $1.81 – $1.87 | Reaffirmed |
| Feb 3, 2025 | Diluted FFO as Adjusted per share | FY2025 | $1.81 – $1.87 | New |
| Feb 3, 2025 | Diluted earnings per common share | FY2025 | $0.30 – $0.36 | New |
| Feb 3, 2025 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2025 | +3% – +4% | New |
| Feb 3, 2025 | Diluted Nareit FFO per share | FY2025 | $1.81 – $1.87 | New |
| Oct 24, 2024 | Diluted FFO as Adjusted per share | FY2024 | $1.79 – $1.81 | Raised |
| Oct 24, 2024 | Diluted earnings per common share | FY2024 | $0.40 – $0.42 | Raised |
| Oct 24, 2024 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2024 | +3.5% – +4.5% | Raised |
| Oct 24, 2024 | Diluted Nareit FFO per share | FY2024 | $1.61 – $1.63 | Raised |
| Oct 24, 2024 | Diluted AFFO per share | FY2024 | $1.56 – $1.58 | Lowered |
| Jul 25, 2024 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2024 | +2.75% – +4.25% | New |
| Jul 25, 2024 | Diluted FFO as Adjusted per share | FY2024 | $1.77 – $1.81 | Raised |
| Jul 25, 2024 | Diluted earnings per common share | FY2024 | $0.27 – $0.31 | Raised |
| Jul 25, 2024 | Diluted Nareit FFO per share | FY2024 | $1.59 – $1.63 | Raised |
| Jul 25, 2024 | Diluted AFFO per share | FY2024 | $1.54 – $1.58 | Lowered |
| Apr 25, 2024 | Diluted FFO as Adjusted per share | FY2024 | $1.76 – $1.80 | Raised |
| Apr 25, 2024 | Diluted earnings per common share | FY2024 | $0.16 – $0.20 | Raised |
| Apr 25, 2024 | Total Merger-Combined Same-Store Cash (Adjusted) NOI growth | FY2024 | +2.5% – +4% | Raised |
| Apr 25, 2024 | Diluted Nareit FFO per share | FY2024 | $1.56 – $1.60 | Raised |
| Apr 25, 2024 | Diluted AFFO per share | FY2024 | $1.53 – $1.57 | Lowered |
| Feb 8, 2024 | Diluted FFO as Adjusted per share | FY2024 | $1.73 – $1.79 | New |
| Feb 8, 2024 | Diluted earnings per common share | FY2024 | $0.07 – $0.13 | New |
| Feb 8, 2024 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2024 | +2.25% – +3.75% | New |
| Feb 8, 2024 | Diluted Nareit FFO per share | FY2024 | $1.54 – $1.60 | New |
| Feb 8, 2024 | Diluted AFFO per share | FY2024 | $1.50 – $1.56 | Lowered |
| Oct 30, 2023 | Diluted FFO as Adjusted per share | FY2023 | $1.76 – $1.78 | Raised |
| Oct 30, 2023 | Diluted earnings per common share | FY2023 | $0.53 – $0.55 | Raised |
| Oct 30, 2023 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2023 | +4.25% – +5.25% | Raised |
| Oct 30, 2023 | Diluted Nareit FFO per share | FY2023 | $1.76 – $1.78 | Raised |
| Jul 27, 2023 | Diluted FFO as Adjusted per share | FY2023 | $1.73 – $1.77 | Raised |
| Jul 27, 2023 | Diluted earnings per common share | FY2023 | $0.49 – $0.53 | Lowered |
| Jul 27, 2023 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2023 | +3.25% – +4.75% | Raised |
| Jul 27, 2023 | Diluted Nareit FFO per share | FY2023 | $1.72 – $1.76 | Raised |
| Apr 27, 2023 | Diluted FFO as Adjusted per share | FY2023 | $1.70 – $1.76 | Reaffirmed |
| Apr 27, 2023 | Diluted earnings per common share | FY2023 | $0.52 – $0.58 | Reaffirmed |
| Apr 27, 2023 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2023 | +3% – +4.5% | New |
| Apr 27, 2023 | Diluted Nareit FFO share | FY2023 | $1.70 – $1.76 | Reaffirmed |
| Feb 7, 2023 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2023 | +2.75% – +4.25% | New |
| Feb 7, 2023 | Diluted FFO as Adjusted per share | FY2023 | $1.70 – $1.76 | New |
| Feb 7, 2023 | Diluted earnings per common share | FY2023 | $0.52 – $0.58 | New |
| Feb 7, 2023 | Diluted Nareit FFO share | FY2023 | $1.70 – $1.76 | New |
| Nov 1, 2022 | Diluted FFO as Adjusted per share | FY2022 | $1.72 – $1.74 | Raised |
| Nov 1, 2022 | Diluted earnings per common share | FY2022 | $0.94 – $0.96 | Lowered |
| Nov 1, 2022 | Total Portfolio Same-Store Cash (Adjusted) NOI growth Guidance | FY2022 | +4.5% – +5.5% | Raised |
| Nov 1, 2022 | Diluted Nareit FFO share | FY2022 | $1.67 – $1.69 | Lowered |
| Aug 2, 2022 | Diluted FFO as Adjusted per share | FY2022 | $1.68 – $1.74 | Reaffirmed |
| Aug 2, 2022 | Diluted earnings per common share | FY2022 | $0.97 – $1.03 | Raised |
| Aug 2, 2022 | Total Portfolio Same-Store Cash (Adjusted) NOI growth Guidance | FY2022 | +3.5% – +5% | Raised |
| Aug 2, 2022 | Diluted Nareit FFO per share | FY2022 | $1.70 – $1.76 | Reaffirmed |
| May 3, 2022 | Diluted FFO as Adjusted per share | FY2022 | $1.68 – $1.74 | Reaffirmed |
| May 3, 2022 | Diluted earnings per common share | FY2022 | $0.58 – $0.64 | Reaffirmed |
| May 3, 2022 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2022 | +3.25% – +4.75% | New |
| May 3, 2022 | Diluted Nareit FFO per share | FY2022 | $1.70 – $1.76 | New |
| Feb 8, 2022 | Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2022 | +3.25% – +4.75% | New |
| Feb 8, 2022 | Diluted FFO as Adjusted per share | FY2022 | $1.68 – $1.74 | New |
| Feb 8, 2022 | Diluted earnings per common share | FY2022 | $0.58 – $0.64 | New |
| Nov 2, 2021 | Diluted FFO as Adjusted per share | FY2021 | $1.58 – $1.62 | New |
| Nov 2, 2021 | Diluted earnings per common share | FY2021 | $0.94 – $0.98 | New |
| Nov 2, 2021 | Blended Total Portfolio Same-Store Cash (Adjusted) NOI growth | FY2021 | +3.5% – +4% | New |
| Nov 2, 2021 | Diluted Nareit FFO per share | FY2021 | $1.09 – $1.13 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Healthpeak Properties filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- News
- Results